Akebia Therapeutics | AKBA - 普通股股本



金融业
股票价格
USD 0.40
资产
USD 342.13M
现金及等价物
USD 159.25M
销售成本
USD 10.34M
流动资产
USD 220.79M
流动负债
USD 162.35M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 20.37M
销售毛利
USD 47.28M
债务利息支出
342.13M
贷款资金
USD 12.78M
市值
USD 89.2M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 18.7M
贸易债权人
USD 7.61M
应收帐款人
USD 47.03M


普通股股本 更改 日
Acadia Pharmaceuticals USD 172.31M 174K 2026-09
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Akebia Therapeutics USD 265.42M 199K 2025-12
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Amgen USD 541M 0 2026-09
Ardelyx USD 249.15M 2.17M 2026-06
Astellas Pharma JPY 1.79B 109K 2026-09
AstraZeneca USD 1.55B 28K 2026-09
Bayer EUR 982.42M 0 2026-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Celltrion KRW 228.57M 1.08M 2026-06
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 54.8M 215.59K 2026-06
Exelixis USD 244.68M 4.21M 2026-09
Fresenius Medical Care EUR 266.11M 3.98M 2026-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
J&J USD 2.41B 1.64M 2026-06
Kangmei Pharma CNY 13.83B 0 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organigram Holdings CAD 140.98M 4.51M 2026-06
Ovoca Bio EUR 29.49M 0 2025-12
Pharma Mar EUR 17.34M 0 2026-09
Prothena USD 51.74M 1.33M 2026-06
PTC Therapeutics USD 83.33M 445K 2026-06
Qiagen NV USD 206.5M 245K 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.2B 0 2026-09
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
Sartorius EUR 69.05M 0 2026-09
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Tectonic Therapeutic USD 19.24M 404.78K 2026-06
Tilray USD 116.52M 5.01M 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12
Zealand Pharma A/S 70.66M 53K 2026-03
Zz Pientze Pharmaceu CNY 603.32M 0 2026-09